Besides TNBC with already phase1b/2 currently enrolling, does anyone have the list of the other 21 cancer types that Cytodyn potentially could be pursuing? Some are obvious from Dr Patterson white paper, like bladder, lung (non-small cell and small cell), other breast cancer (HER2+ and HR+), pancreatic, colorectal, head and neck. Each of cancer types is potential big market in itself.

https://incelldx.com/incelldx-content/uploads...rt-003.pdf